尼群地平(Nitrendipine)是一种抗高血压新药,属于钙通道抑制剂。我们以南京制药厂生产之片剂舌下给药,观察其急性降压作用。一、对象与方法1.观察对象:健康人12例(男5例、女7例),平均52.5岁。高血压病75例(男32例、女43例),平均53.1岁。其中Ⅰ期22例、Ⅱ期46例、Ⅲ期7例。诊断与分期按1979年郑州会 Nitrendipine is a new antihypertensive drug that is a calcium channel inhibitor. We use the tablets manufactured by Nanjing Pharmaceutical Factory for sublingual administration to observe its acute antihypertensive effect. First, the object and method 1.Objective: 12 healthy subjects (5 males and 7 females), average 52.5 years old. Hypertension in 75 cases (32 males and 43 females), an average of 53.1 years old. Of which 22 cases of stage Ⅰ, 46 cases of stage Ⅱ, 7 cases of stage Ⅲ. Diagnosis and staging by 1979 will be in Zhengzhou